GROUP ONE TRADING, L.P. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V907. A total of 3 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$303,502
+68.6%
115,400
+126.3%
0.00%0.0%
Q2 2023$180,030
+1065.2%
51,000
+920.0%
0.00%
Q1 2023$15,450
-88.8%
5,000
-84.7%
0.00%
Q4 2022$138,321
+92.1%
32,700
+7.9%
0.00%
Q3 2022$72,000
+278.9%
30,300
+359.1%
0.00%
Q2 2022$19,000
-66.7%
6,600
-66.8%
0.00%
Q1 2022$57,000
+533.3%
19,900
+541.9%
0.00%
Q4 2021$9,000
-78.0%
3,100
-46.6%
0.00%
Q3 2021$41,000
-78.5%
5,800
-72.1%
0.00%
Q2 2021$191,000
+478.8%
20,800
+511.8%
0.00%
Q1 2021$33,000
-86.9%
3,400
-86.2%
0.00%
Q4 2020$252,000
+58.5%
24,600
+55.7%
0.00%
Q3 2020$159,000
-16.3%
15,800
-13.2%
0.00%
-100.0%
Q2 2020$190,000
-50.5%
18,200
-60.0%
0.00%
-66.7%
Q1 2020$384,000
-61.3%
45,500
-59.9%
0.00%
-57.1%
Q4 2019$992,000
+134.0%
113,400
+187.8%
0.01%
+133.3%
Q3 2019$424,000
-11.7%
39,400
+4.2%
0.00%
-25.0%
Q2 2019$480,000
-54.3%
37,800
+39.5%
0.00%
-66.7%
Q1 2019$1,051,000
+263.7%
27,100
+90.8%
0.01%
+300.0%
Q4 2018$289,000
-53.3%
14,200
+5.2%
0.00%
-40.0%
Q3 2018$619,000
-76.3%
13,500
-69.4%
0.01%
-77.3%
Q2 2018$2,609,000
+367.6%
44,100
+437.8%
0.02%
+266.7%
Q1 2018$558,000
-89.8%
8,200
-85.3%
0.01%
-84.6%
Q4 2017$5,496,000
-53.2%
55,600
-43.3%
0.04%
-63.6%
Q3 2017$11,747,000
+69.5%
98,100
+23.7%
0.11%
+48.6%
Q2 2017$6,931,000
+996.7%
79,300
+366.5%
0.07%
+928.6%
Q1 2017$632,000
+12.5%
17,000
-7.1%
0.01%
+40.0%
Q4 2016$562,000
-78.7%
18,300
-53.6%
0.01%
-82.8%
Q3 2016$2,642,000
+1146.2%
39,400
+454.9%
0.03%
+866.7%
Q2 2016$212,000
+20.5%
7,100
+18.3%
0.00%
+50.0%
Q1 2016$176,000
-77.6%
6,000
-40.0%
0.00%
-77.8%
Q4 2015$784,000
+131.3%
10,000
+122.2%
0.01%
+80.0%
Q3 2015$339,000
-72.6%
4,500
-57.5%
0.01%
-70.6%
Q2 2015$1,238,000
+1203.2%
10,600
+2020.0%
0.02%
+1600.0%
Q4 2014$95,000
-33.6%
500
-16.7%
0.00%
-50.0%
Q3 2014$143,000
-92.3%
600
-97.9%
0.00%
-93.1%
Q2 2014$1,861,000
+1689.4%
28,200
+2720.0%
0.03%
+1350.0%
Q1 2014$104,000
-90.6%
1,000
-90.7%
0.00%
-88.2%
Q4 2013$1,108,00010,7000.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 462$474,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 24,600$252,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders